In 2008, sales of blood gas monitoring products in the European countries of France, Germany, Italy, Spain, and the United Kingdom (U.K.) totaled approximately $660.1 million; over the forecast period covered by this report, sales of these products are expected to increase at a compound annual rate of 3.3%, reaching an estimated $778.3 million in the year 2013.
This dynamic, new report from Medtech Insight includes analyses of products, markets, competitors, and opportunities in the area of blood gas monitoring. Market segments covered in this report include arterial blood gas sampling products, capnography/end-tidal carbon dioxide monitors, laboratory-based blood gas analyzers, point of care blood gas analyzers, and pulse oximeters. This report also provides an analysis of critical care in Europe as well as an overview of the healthcare markets of France, Germany, Italy, Spain, and the U.K.
EXECUTIVE SUMMARY i. Critical Care Overview ii. European Markets for Blood Gas Monitoring Products a. Market Analysis iii. Methodology Exhibit ES-1: Europe, Blood Gas Monitoring Products, Market Forecast, 2008-2013 1. EUROPEAN HEALTHCARE MARKETS 1.1 The European Union 1.1.1 A Common Currency 1.1.2 Regulatory Policies 1.1.3 Reimbursement 1.1.4 Healthcare Spending 1.2 Selected European National Healthcare Profiles 1.2.1 France 22.214.171.124 Healthcare Organization and Reform 126.96.36.199 Hospital Services 188.8.131.52 Medical Device Reimbursement 1.2.2 Germany 184.108.40.206 Healthcare Organization and Reform 220.127.116.11 Hospital Services 18.104.22.168 Medical Device Reimbursement 1.2.3 Italy 22.214.171.124 Healthcare Organization and Reform 126.96.36.199 Hospital Services 188.8.131.52 Medical Device Reimbursement 1.2.4 Spain 184.108.40.206 Healthcare Organization and Reform 220.127.116.11 Hospital Services 18.104.22.168 Medical Device Reimbursement 1.2.5 United Kingdom 22.214.171.124 Healthcare Organization and Reform 126.96.36.199 Hospital Services 188.8.131.52 Medical Device Reimbursement Exhibit 1-1: European Union, Medical Devices Risk Classification System Exhibit 1-2: Europe, Population Statistics Comparison for the Years 2008 and 2018 Exhibit 1-3: France, Selected National Healthcare Statistics Exhibit 1-4: Germany, Selected National Healthcare Statistics Exhibit 1-5: Italy, Selected National Healthcare Statistics Exhibit 1-6: Spain, Selected National Healthcare Statistics Exhibit 1-7: United Kingdom, Selected National Healthcare Statistics 2. OVERVIEW OF THE CRITICAL CARE ENVIRONMENT 2.1 Conditions Treated in the Critical Care Unit 2.2 Critical Care Unit Staffing 2.2.1 Intensivists 2.2.2 Nurses and Other Allied Healthcare Professionals 2.3 Critical Care Units, by Size and Type 2.4 Equipment and Products Used in the Critical Care Setting 2.4.1 Invasive and Noninvasive Equipment and Products 2.4.2 Transport Equipment and Products 2.5 Critical Access Hospital Designation 2.6 Issues Affecting Critical Care Delivery 2.6.1 Patient Demographics 2.6.2 Managed Care 2.6.3 Healthcare Personnel Shortages 2.6.4 Trends in Critical Care Product Purchasing Exhibit 2-1: 2006, Number of Anesthetists/Intensivists in Selected European Countries Exhibit 2-2: Selected Critical Care Nursing and Allied Healthcare Responsibilities Exhibit 2-3: 2006, Number of Emergency Rooms and Beds in Selected European Countries Exhibit 2-4: 2006, Total Equipped Positions, by Type of Intensive Care Unit and Facility in Selected European Countries Exhibit 2-5: 2006, France, Total Equipped Positions, by Type of Intensive Care Unit and Facility Exhibit 2-6: 2006, Germany, Total Equipped Positions, by Type of Intensive Care Unit and Facility Exhibit 2-7: 2006, Italy, Total Equipped Positions, by Type of Intensive Care Unit and Facility Exhibit 2-8: 2006, Spain, Total Equipped Positions, by Type of Intensive Care Unit and Facility Exhibit 2-9: 2006, United Kingdom, Total Equipped Positions, by Type of Intensive Care Unit and Facility 3. EUROPEAN MARKETS FOR CRITICAL CARE BLOOD GAS MONITORING PRODUCTS 3.1 Overview of Blood Gases 3.1.1 Arterial Blood Gas Sampling 3.1.2 Arterial Blood Gas Monitoring Methods 3.2 Point of Care Blood Gas Analyzers 3.2.1 Market Forecast 3.2.2 Competitive Analysis 3.3 Laboratory-Based Blood Gas Analyzers 3.3.1 Market Forecast 3.3.2 Competitive Analysis 3.4 Arterial Blood Gas Sampling Devices 3.4.1 Market Forecast 3.4.2 Competitive Analysis 3.5 Pulse Oximeters 3.5.1 Market Forecast 3.5.2 Competitive Analysis 3.6 Capnography/End-Tidal Carbon Dioxide Monitoring 3.6.1 Market Forecast 3.6.2 Competitive Analysis 3.7 Combined Market Forecast, Blood Gas Monitoring Systems Exhibit 3-1: 2009, Selected Point of Care Blood Gas Testing Products Exhibit 3-2: Europe, Point of Care Blood Gas Testing Products, Market Forecast, 2008-2013 Exhibit 3-3: 2008, Europe, Point of Care Blood Gas Testing Products Market, Share by Supplier Exhibit 3-4: 2009, Selected Laboratory-Based Blood Gas Analyzers Exhibit 3-5: Europe, Laboratory-Based Blood Gas Analyzers, Market Forecast, 2008-2013 Exhibit 3-6: 2008, Europe, Laboratory-Based Blood Gas Analyzers Market, Share by Supplier Exhibit 3-7: 2009, Selected Arterial Blood Gas Sampling Devices Exhibit 3-8: Europe, Arterial Blood Gas Sampling Devices, Market Forecast, 2008-2013 Exhibit 3-9: 2008, Europe, Arterial Blood Gas Sampling Devices Market, Share by Supplier Exhibit 3-10: 2009, Selected Pulse Oximetry Products Exhibit 3-11: Europe, Pulse Oximetry Products, Market Forecast, 2008-2013 Exhibit 3-12: 2008, Europe, Pulse Oximetry Monitors Market, Share by Supplier Exhibit 3-13: Advantages and Disadvantages of Mainstream and Sidestream Capnography Sampling Exhibit 3-14: 2009, Selected Capnography-Only Units Exhibit 3-15: 2009, Selected Capnography/Oximetry Units Exhibit 3-16: Europe, Capnography/End-Tidal Carbon Dioxide Monitoring Products, Market Forecast, 2008-2013 Exhibit 3-17: 2008, Europe, Capnography/End-Tidal Carbon Dioxide Monitors Market, Share by Supplier Exhibit 3-18: Europe, Blood Gas Monitoring Products, Combined Market Forecast, 2008 to 2013 4. COMPANY PROFILES 4.1 Abbott Laboratories 4.2 Covidien LTD 4.3 Danaher Corporation 4.4 General Electric Company 4.5 Masimo Corporation 4.6 Roche Holding AG 4.7 Royal Philips Electronics NV 4.8 Siemens AG 4.9 Smiths Group PLC 4.10 Werfen Group S.A. APPENDIX: COMPANY LISTING